- First-in-human trial announced for DNA nanobots engineered to selectively target and destroy cancer cells, marking a milestone in programmable molecular medicine.  
- Smartphone-linked closed-loop “artificial pancreas” for Type-1 diabetes discussed; participants note that consumer-grade continuous glucose monitors remain prescription-only and expensive.  
- Berkeley paper on “Self-photosensitization of nonphotosynthetic bacteria for solar-to-chemical production” shared, describing hybrid living photovoltaic systems that shuttle electrons to microbes for on-demand chemical synthesis.  
- Open-source microfluidics progress: a BRL-CAD model of a peristaltic pump and a laser-power controller (PWM → LM317) are being built to improve g-code-driven fabrication workflows.  
- Channel members debate the absence of explicit road-mapping; nmz787_i invites review of distributed notes on “design arbitrary protein nanomachines” tools, while others commit to publishing their own roadmaps.  
- Graphene “optical capacitors” for neuromorphic chips that merge biophysics with semiconductors linked (ExtremeTech article), greeted with skepticism about headline claims.  
- Technical walkthrough documented for enabling Intel Skylake HD 530 iGPU, KVM, and CUDA acceleration for GROMACS molecular-dynamics simulations under Linux.  
- A participant references a “shotgun-effect” Alzheimer’s study focused on boosting mitochondrial performance en masse, noting they are personally replicating the experiment, and later locates the paper (URL not re-posted).